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Abstract Our previous evidence suggests that heterogeneous
nuclear ribonucleoprotein (hnRNP) A1 plays a part in the reg-
ulation of the Cyp2a5 gene by interacting with the 3P untrans-
lated region (UTR) of the CYP2A5 mRNA. However, the exact
role of this interaction is not clear. The aim of the present work
was to gain further insight into the regulation process of
Cyp2a5. For this purpose the 3P UTR of CYP2A5 was fused
to the coding region of luciferase mRNA. Luciferase recombi-
nants containing either the full length 3P UTR, or the 3P UTR
lacking a previously described 71 nucleotide (nt) region (the
hnRNP A1 primary binding site), were transiently expressed
in cells expressing or lacking hnRNP A1. The expression of
the luciferase recombinants was examined both at mRNA and
enzyme activity levels. The results disclosed that the presence of
hnRNP A1 was required for the high expression of the recombi-
nant carrying the full length 3P UTR of CYP2A5. Deletion of
the hnRNP A1 primary binding site dramatically modi¢ed the
expression pattern: the mRNA levels and luciferase activities of
the deletion mutant were independent from hnRNP A1. These
results conclusively demonstrate that the 71 nt region in the 3P
UTR of CYP2A5 mRNA can confer hnRNP A1-dependent reg-
ulation to a gene. In addition, comparison of RNA levels and
luciferase activities suggested that regions £anking the hnRNP
A1 binding site could regulate translation of the CYP2A5
mRNA. These results are consistent with a model in which the
binding of hnRNP A1 to the 71 nt putative hairpin-loop region
in the CYP2A5 mRNA 3P UTR upregulates mRNA levels pos-
sibly by protecting the mRNA from degradation.
5 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The cytochrome P450 mono-oxygenases (CYPs) constitute
a large and diverse family of enzymes responsible for the
initial oxidation of various lipophilic compounds, including
xenobiotics and endogenous substrates. These enzymes are
often inducible, and their expression can be regulated at dif-
ferent levels, such as gene transcription, pre-mRNA process-
ing, mRNA and protein stabilization [1]. The discovery of the
‘orphan’ nuclear receptor superfamily notably advanced the
understanding of the mechanisms by which xenochemicals
transcriptionally a¡ect the expression of CYP genes [2,3].
The post-transcriptional regulation of CYP genes, in particu-
lar the possible cis-acting elements and trans-acting proteins
involved, however, remain to be elucidated. The interaction of
proteins with regulatory elements in the 3P untranslated region
(3P UTR) of mRNA has been described in a wide variety of
systems [4]. These studies suggest multiple roles of the 3P UTR
of eukaryotic mRNA in determining mRNA localization [5],
controlling polyadenylation [6], regulating mRNA stability
[7,8] and controlling translation initiation [9].
We have studied the molecular mechanisms involved in the
post-transcriptional regulation of the Cyp2a5 gene. Previous
work has revealed that Cyp2a5 is upregulated through mRNA
stabilization [10]. In an e¡ort to characterize the regulatory
factors involved, we have found that the binding of a 37/39
kDa protein to a 71 nucleotide (nt) long putative hairpin-loop
in the CYP2A5 3P UTR is stimulated upon stabilization of the
mRNA [11,12]. Geneste et al. [11] also established that during
stabilization an elongation of the CYP2A5 mRNA poly(A)
tail takes place, suggesting that the binding of the 37/39
kDa protein stabilizes the CYP2A5 mRNA by controlling
the length of its poly(A) tail. The 37/39 kDa protein has
recently been identi¢ed as the heterogeneous nuclear ribonu-
cleoprotein (hnRNP) A1, and overexpression studies con-
ducted in primary mouse hepatocytes imply that hnRNP A1
is an important regulator of the Cyp2a5 gene expression in
vivo [13]. However, the exact role of hnRNP A1 in the
Cyp2a5 regulation remains to be elucidated. The aim of this
work was to investigate how hnRNP A1 regulates the Cyp2a5
expression, in particular what role the interaction of hnRNP
A1 with the 71 nt long putative hairpin-loop at the 3P UTR of
CYP2A5 mRNA plays in the regulation process. For this
purpose we used the CB3+/3 cells, expressing or not the
hnRNP A1 [14]. The full length CYP2A5 3P UTR, or the 3P
UTR lacking the 71 nt hairpin-loop region was fused to the
coding region of luciferase mRNA, and these recombinants
were transiently expressed in CB3+ and CB33 cells. The re-
sults show that interaction of hnRNP A1 with the 71 nt hair-
pin-loop is critical for a high expression of the gene. In the
absence of hnRNP A1 this hairpin-loop region seems to pro-
mote degradation of the mRNA. Moreover, deletion of the
binding site leads to higher mRNA levels that can no longer
be regulated by hnRNP A1. These results are consistent with
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a model proposed for other genes where hnRNP A1 upregu-
lates mRNA levels by preventing a nuclease attack at a desta-
bilizing element.
2. Materials and methods
2.1. Cell cultures
CB3+ and CB33 cells were maintained in MEM medium alpha
supplemented with 10% (v/v) fetal bovine serum and 800 Wg/ml genet-
icin (Gibco1, Invitrogen AB, Sweden). The cells were grown in sus-
pension, as described by Ben-David et al. [14].
2.2. Luciferase reporter gene constructs
The luciferase reporter vector, pGL3 control, was purchased from
Promega (Scandinavian Diagnostic Services, Falkenberg, Sweden).
Downstream of the luciferase gene, at the XbaI site, either the full
length CYP2A5 3P UTR or the delta71 CYP2A5 3P UTR (lacking the
71 nt hnRNP A1 primary binding site) was introduced (Scheme 1).
Polymerase chain reaction (PCR) was used to generate the CYP2A5
3P UTR DNA fragments. To allow subcloning of the fragments into
the pGL3 control vector, the XbaI restriction site (TCTAGA) was
introduced in the forward primer, and the AvrII restriction site
(CCTAGG) in the reverse primer. Oligonucleotides are shown in
sense orientation with the restriction sites underlined. Nucleotide po-
sitions referring to the CYP2A5 sequence were assigned according to
Squires and Negishi [15].
The forward primer, common to both constructs, was: CYP2A5
1486^1689, ACACACTCTAGAGCCTGGGCTGCATGAGGTTAA-
AGGGAATG. The reverse primers were the following: Full length
CYP2A5 1689^1486, ACACACCCTAGGATTCCTATTGACAACA-
TAGT; Delta71 CYP2A5 1689^1655//1584^1486, ACACACCCTAG-
GTGCCATAAATAATATCTACTTTTATTATTTTATT//TCAGTG-
TCCTCTGTTTCTTCTGTACCTTTGACC.
The PCR-ampli¢ed fragments were double digested with XbaI and
AvrII before ligation into the XbaI digested pGL3 control vector. All
constructs were sequenced to ascertain the right orientation in the
vector, using Dye-labelled Terminator for the sequence reaction and
an ABI377 DNA sequencer for analysis.
2.3. Transfection experiments
The luciferase reporter gene constructs were transiently transfected
into CB3+ and CB33 cells with the DMRIE-C Reagent transfection
system (Gibco1, Invitrogen AB, Sweden) and according to the man-
ufacturer’s protocol. Co-transfection with a L-galactosidase plasmid,
pCMV-SPORT-L-gal (Gibco1, Invitrogen AB, Sweden) allowed
monitoring of transfection e⁄ciencies.
2.4. Luciferase assay
Transfected CB3+/3 cells were assayed for luciferase activity 48 h
after transfection. All reagents required for the luciferase assay were
from Promega, SDS, Sweden. The cells were lysed and harvested in
reporter lysis bu¡er (RLB) and immediately put on dry ice. Before
luminescence reading, the thawed cell extracts were centrifuged at
9500Ug for 2 min: 30 Wl cell extract was added to 100 Wl luciferase
reagent, and the luminescence in relative light units (RLU) was read
in a TD-20/20 luminometer (Turner Designs, Scandinavian Diagnostic
Services, Sweden). The RLU values were normalized to the L-galac-
tosidase activities.
2.5. L-Galactosidase assay
To 50 Wl cell extracts, 250 Wl bu¡er Z (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1.0 mM MgSO4, 50 mM L-mercaptoethanol)
was added. The samples were incubated for 2 h at room temperature
after addition of 50 Wl of a 4 mg/ml ONPG (O-nitrophenyl-L-D-ga-
lactopyranoside, Sigma-Aldrich Sweden AB). Subsequently, the reac-
tion was stopped by adding 250 Wl of 1.0 M Na2CO3 and the absor-
bance measured spectrophotometrically at 420 nm.
2.6. Nuclear and cytoplasmic proteins
Cells (5U106) were centrifuged at 2000Ug for 3 min and washed
twice in phosphate bu¡ered saline (PBS). Following this, the pellet
was resuspended in 400 Wl bu¡er A (10 mM HEPES^KOH pH 7.9; 10
mM KCl; 1.5 mM MgCl2 ; 0.5 mM dithiothreitol (DTT); 0.2 mM
phenylmethylsulfonyl £uoride (PMSF); 10 Wg/ml leupeptin and 0.4%
Igepal) and left on ice for 60 min. After 30 s of vortexing, at max-
imum speed, cells were homogenized by pestling (10 strokes U3) and
centrifuged at 11 000Ug and 4‡C for 10 min. The supernatant con-
taining the cytoplasmic proteins was stored at 380‡C. The remaining
pellet containing the nuclei was resuspended in 100 Wl cold bu¡er B
(20 mM HEPES^KOH pH 7.9; 25% glycerol; 1.5 mM MgCl2 ; 420
mM NaCl; 0.2 mM ethylenediamine tetraacetic acid (EDTA); 0.5
mM DTT; 0.5 mM PMSF; and 0.4% Igepal) and stirred with a
magnetic stirrer for 30 min at 4‡C. The suspension was homogenized
by pestling (10 strokesU2) and centrifuged at 11 000Ug for 15 min at
4‡C. The nuclear proteins contained in the supernatant were stored at
380‡C.
2.7. Western blot
Proteins (30 Wg) were isolated as described, and separated by so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) (12%) and blotted onto a nitrocellulose membrane, Hy-
bond1-C extra (Amersham Biosciences, Uppsala, Sweden). A mono-
clonal anti-hnRNP A1 antibody, 9H10, kindly provided by Dr. G.
Dreyfuss (Howard Hughes Medical Institute, University of Philadel-
phia, USA) was used in a 1:1000 dilution. All solutions contained 5%
non-fat dry milk and the detection was performed with the ECL
Western blotting analysis system (Amersham Biosciences, Uppsala,
Sweden).
2.8. Northern blot
Total RNA from transfected CB3+/3 cells was isolated using the
Qiagen Miniprep kit (Qiagen, VWR International, Stockholm, Swe-
den). RNA was run on a 1.2% agarose/formaldehyde gel and trans-
ferred onto a Hybond1-N nylon membrane (Amersham Biosciences,
Uppsala, Sweden). The amount of RNA loaded was determined ac-
cording to the transfection e⁄ciency, as described in more detail in
Section 3. Following transfer, the membrane was UV crosslinked and
hybridized overnight at 65‡C in a modi¢ed Church bu¡er (0.25 M
phosphate bu¡er, 7% SDS, 1 mM EDTA) with [K-32P]dCTP-labelled
cDNA (1.7U107 cpm) corresponding to the luciferase-coding region.
Radiolabelling was performed with the Megaprime labelling kit
(Amersham Biosciences, Uppsala, Sweden).
For the densitometric analysis the ¢lm was scanned with a Scanjet
4c scanner (Hewlett Packard, Palo Alto, CA, USA), and the quanti-
¢cation performed with the software NIH Image 1.61 (http://rsb.
info.nih.gov/nih-image/).
2.9. Expression and puri¢cation of recombinant histidine-tagged
hnRNP A1
The histidine-tagged recombinant hnRNP A1, generously provided
by Dr. J.-P. Kreivi (Uppsala Biomedical Centre, Uppsala University,
Sweden), was expressed in Escherichia coli BL21(DE3)/pLysS as de-
scribed by Mayeda et al. [16] and puri¢ed with a HiTrap Chelating
HP a⁄nity column (Amersham Pharmacia Biotech, Uppsala, Swe-
den).
2.10. Synthesis of radiolabelled RNA
The 71 nt RNA probe (containing the hnRNP A1 primary binding
site) was synthesized by in vitro transcription of CYP2A5 cDNA
ampli¢ed by PCR [12]. The PCR-ampli¢ed cDNA was transcribed
with T7 RNA polymerase in the presence of [K-32P]UTP using stan-
dard protocols (Promega Corporation, ‘Protocols and Applications
Guide’, 3rd Edn., 1996).
2.11. UV crosslinking
A detailed protocol of the reaction is described by Geneste et al.
[11]. In brief, 5 Wg of nuclear and 10 Wg of cytoplasmic proteins were
used in the binding reactions. The samples were exposed to UV light
for 20 min in a Spectrolinker XL-1000 UV crosslinker (Spectronics,
Westbury, NY, USA). Unprotected RNA was digested with 2 Wg of
RNase A at 37‡C for 20 min. The samples were denatured under non-
reducing conditions and the proteins were separated by SDS^PAGE
(12%). Ultimately, the gel was dried and autoradiographed overnight.
2.12. Immunoprecipitation
Immunoprecipitation was performed according to Hamilton et al.
[17]. The UV crosslinked CYP2A5 RNA/protein complexes (14 Wg
cytoplasmic proteins and 7 Wg nuclear proteins) were incubated with
a 1:500 dilution of the anti-hnRNP A1 antibody, 9H10, and subse-
quently immunoprecipitated with protein A-Sepharose beads (Amer-
FEBS 26922 20-1-03
T. Glisovic et al./FEBS Letters 535 (2003) 147^152148
sham Biosciences, Uppsala, Sweden). After washing, the immunopre-
cipitated complexes were denatured and separated by SDS^PAGE
(12%), and radiolabelled complexes were detected with autoradiogra-
phy.
3. Results
3.1. Expression of hnRNP A1 and its CYP2A5 mRNA binding
activity in CB3+/3 cells
The CB3 cells have lost the ability to express the hnRNP
A1 protein due to a retroviral insertion in one allele of the
hnrnpa1 gene, and a loss of the other allele [14]. These cells
have been transformed with a vector containing the mouse
hnRNP A1-coding region (CB3+), or with the corresponding
empty vector (CB33) [14]. A ¢rst set of experiments was
conducted in order to con¢rm the lack of hnRNP A1 expres-
sion and CYP2A5 mRNA binding activity in CB33 cells.
Western blot analysis with a monoclonal antibody raised
against the hnRNP A1 revealed that the protein is expressed
in CB3+, but not in CB33 cells (Fig. 1A), a result in accor-
dance with previous reports on the CB3+/3 cells [14]. In
addition, a UV crosslinking assay with the 71 nt hairpin-
loop region of the CYP2A5 mRNA as a probe, containing
the primary binding site of the hnRNP A1 [11], con¢rmed
that a UV crosslinked complex was obtained only with nu-
clear and cytoplasmic protein extracts from CB3+ cells [13]
and this complex was identical in size to that formed by a
puri¢ed recombinant hnRNP A1 and the 71 nt RNA probe
(Fig. 1B). With immunoprecipitation, the complex formed
with CB3+ cell extracts was shown to contain the hnRNP
A1 (Fig. 1C). In both UV crosslinking and immunoprecipita-
tion experiments larger size protein complexes were detected,
most probably due to hnRNP A1 homomerization as de-
scribed by Cartegni et al. [18] and Kim et al. [19].
3.2. Role of the CYP2A5 3P UTR for the luciferase gene
expression in the CB3+ and CB33 cells
Having validated that exclusively the CB3+ cells expressed
the hnRNP A1, and that the binding to the CYP2A5 mRNA
was maintained in these cells, both CB3+ and CB33 cells
were transiently transfected with luciferase reporter constructs
(Scheme 1), in order to see how interaction of hnRNP A1
with the 3P UTR of the CYP2A5 mRNA could control gene
expression. Total RNA and protein from transfected cells
were isolated 48 h post-transfection, a time point at which
the transient expression of the reporter constructs was at its
peak (data not shown). The expression of the recombinant
genes was ¢rst analyzed at the mRNA level, by Northern
blot (Fig. 2). The luciferase mRNA levels were quanti¢ed
with the NIH-Image program (see Section 2). The amount
of RNA used in the analysis was normalized for variances
in the transfection e⁄ciencies using L-galactosidase activity
values. As a control for correct normalization we measured
the level of glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH) mRNA, which is expected to vary inversely in
proportion to the L-galactosidase activities. Densitometric
analysis showed that the GAPDH mRNA levels re£ected
the correction performed in the L-galactosidase normalization
(data not shown). The recombinant luciferase mRNA was
detected at the expected size ofV3 kb. Luciferase transcripts
of higher molecular weight were also present and their expres-
sion seemed to follow that of the luciferase mRNA. We did
not investigate their identity further but these transcripts may
be due to cryptic transcription start sites within the plasmid
[20].
When the luciferase recombinant containing the full length
CYP2A5 3P UTR was transfected into the CB3+ cells, higher
luciferase mRNA levels were detected compared to the control
luciferase mRNA not containing the CYP2A5 3P UTR
(Fig. 2). However, transfection into CB33 cells resulted in
markedly reduced levels of the CYP2A5 3P UTR-containing
B.
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hnRNP A1
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      C           N
37/39 kDa
  C           N
CB3    +     -    +     -
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C.   C          N
CB3    +    -    +     -
37/39 kDa
Fig. 1. Characterization of hnRNP A1 in CB3+ and CB33 cells :
A: Western blot. Nuclear and cytoplasmic proteins (30 Wg) from
CB3+ and CB33 cells were resolved by SDS^PAGE (12%) and
transferred onto a nitrocellulose membrane. The hnRNP A1 protein
was detected with the monoclonal anti-hnRNP A1 antibody (9H10).
B: UV crosslinking of nuclear and cytoplasmic proteins from CB3+
and CB33 cells and the 71 nt CYP2A5 RNA probe. UV crosslink-
ing was performed with 5 Wg of nuclear (N) or 10 Wg of cytoplasmic
(C) proteins from CB3+ and CB33 cells, or 10 Wg of the recombi-
nant histidine-tagged hnRNP A1 (his-A1), and the radiolabelled 71
nt CYP2A5 RNA probe. The 37/39 kDa complex is indicated.
C: Immunoprecipitation of RNA/protein complexes. UV crosslink-
ing was performed on 7 Wg of nuclear (N) or 14 Wg of cytoplasmic
(C) proteins from CB3+ and CB33 cells incubated with the radiola-
belled 71 nt CYP2A5 RNA probe, corresponding to the hnRNP A1
primary binding site. The RNA/protein complexes were immunopre-
cipitated with the anti-hnRNP A1 antibody (9H10), and resolved by
SDS^PAGE (12%). The hnRNP A1-containing 37/39 kDa complex
is indicated.
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luciferase mRNA (Fig. 2). In fact, the mRNA level was below
the control pGL3 mRNA. Deletion of the hnRNP A1 binding
site from the 3P UTR dramatically changed this pattern: in
this case no di¡erence was observed between the levels of the
control pGL3 mRNA and the delta71 3P UTR-containing lu-
ciferase mRNA, in either of the two cell lines (Fig. 2), sug-
gesting that hnRNP A1 no more could a¡ect the recombinant
RNA levels.
The luciferase construct containing the full length CYP2A5
3P UTR equally resulted in a strongly elevated luciferase ac-
tivity when expressed in the CB3+ cells, compared to the
control pGL3 vector, but transfection of these constructs
into the CB33 cells gave similarly low enzyme activities
(Fig. 3). Notably, deletion of the hnRNP A1 binding site
from the 3P UTR resulted in a higher enzyme activity/
mRNA ratio as compared to that obtained with the pGL3
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Scheme 1. Schematic presentation of the CYP2A5 luciferase reporter recombinants. The 71 nt putative hairpin-loop is indicated. The di¡erent
parts of the CYP2A5 3P UTR were introduced downstream of the luciferase-coding region, at the XbaI restriction site.
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Fig. 2. A: Expression of luciferase recombinants in CB3+ and CB33 cells 48 h after transfection analyzed by Northern blot. Normalized
amounts of RNA (as described in Section 3) were hybridized with a radiolabelled probe recognizing the luciferase-coding region. The luciferase
mRNA is detected at the expected size of V3 kb. B: Quanti¢cation of pGL3, full length CYP2A5 3P UTR (FL) and delta71 luciferase mRNA
amounts in CB3+ and CB33 cells.
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control. This suggests that regions £anking the hairpin-loop
contribute to e⁄cient translation (Fig. 3).
4. Discussion
In this work, the interplay between the hnRNP A1 protein
and the putative 71 nt hairpin-loop of the 3P UTR of CYP2A5
mRNA was demonstrated to be essential for the expression of
the CYP2A5 3P UTR-containing luciferase gene. In CB3+
cells where the hnRNP A1 was present, the full length
CYP2A5 3P UTR-containing reporter gene was highly ex-
pressed, both at mRNA and enzyme levels, whereas in
CB33 cells lacking hnRNP A1, the same gene was expressed
at low levels. These results strongly suggest that the 71 nt
region is a cis-acting element, which through interaction
with the hnRNP A1 controls the levels of the 3P UTR-con-
taining mRNA. Since the 3P UTR-containing mRNA was ex-
pressed at levels even lower than the control mRNA in the
absence of hnRNP A1, the 71 nt region seemed to act as a
destabilizing element protected by the hnRNP A1. The
present ¢ndings are in accordance with a model postulated
by Chen et al. [21], stating that the binding of hnRNP pro-
teins to sequences in the 3P UTR of c-fos and granulocyte
macrophage-colony-stimulating factor (GM-CSF) mRNAs re-
sults in a stabilizing e¡ect on the mRNA. The suggested
mechanism is that hnRNPs by binding to regions in the 3P
UTR hinder binding of proteins with an mRNA destabilizing
function. Our results support this model : the binding of
hnRNP A1 to the 71 nt primary binding site in the 3P UTR
of CYP2A5 mRNA could protect the mRNA from RNases
and thereby maintain the high level of expression of the gene.
Recent work on the expression of Cyp2a5 in primary mouse
hepatocytes [13] has revealed that the level of the CYP2A5
transcript increases when hnRNP A1 is overexpressed, anoth-
er piece of evidence in support of our model in which hnRNP
A1 by binding to the 3P UTR of CYP2A5 mRNA has a
stabilizing e¡ect on the mRNA. In further support of such
a model, hnRNP A1 has newly been reported to protect telo-
meric sequences against degradation by nucleases [22], again
stressing the role of hnRNP A1 as a possible factor protecting
certain nucleic acids against nuclease attack.
The delta71 recombinant gave similar luciferase activities in
both CB3+ and CB33 cells, as well as comparable mRNA
levels. Clearly, the expression of this construct was not depen-
dent on hnRNP A1. Interestingly, despite equally low pGL3
and delta71 mRNA levels in both cell lines, the paralleling
enzyme activity was higher for the delta71 recombinant com-
pared to the pGL3. This suggests that the di¡erence in ex-
pression is at the translational level ; hence the CYP2A5 3P
UTR sequences £anking the hairpin-loop in the mRNA may
stimulate translation. The role of the 3P UTR in translation
has been extensively studied [23,24], and this region of the
mRNA is recognized as enhancing the initiation of translation
in many mRNA species, by binding factors that interact with
the cap structure at the 5P end of the mRNA molecule [25].
No such factors have so far been identi¢ed for the CYP2A5.
The results presented here provide conclusive evidence for
hnRNP A1 being a central player in the regulation of the
Cyp2a5 expression through its interaction with the hairpin-
loop at the 3P UTR. They also suggest that hnRNP A1 works
by antagonizing a CYP2A5 mRNA destabilizing factor. The
results thus provide a mechanistic explanation for our pre-
vious data [11^13]. While this mode of regulation of mRNA
stability has been shown for other genes [26] no data on the
existence of such factors in the case of Cyp2a5, nor any other
Cyp gene, are available. Experiments aiming at identifying
and characterizing factors responsible for CYP2A5 mRNA
degradation are ongoing in our research group.
Earlier work has shown that Cyp2a5 is upregulated in the
liver by di¡erent conditions causing cellular stress, such as
liver injury [27] and viral infection [28]. As the hnRNP A1
also has been shown to be activated in certain stress condi-
tions [29,30], it is tempting to speculate that this protein plays
a role in the upregulation of Cyp2a5 (and perhaps other
genes) in various liver pathologies. To investigate this possi-
bility and to study the processes involved is a goal of our
future research.
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Fig. 3. Luciferase activities in CB3+ and CB33 transfected cells. Protein extracts from cells transfected with the pGL3, full length CYP2A5 3P
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